NCT05007353

Brief Summary

A study in Finland found that a multidomain intervention of physical activity, nutritional guidance, cognitive training, social activities and management of vascular risk factors slowed cognitive decline in healthy older adults at increased risk of cognitive decline. A 6-month pilot study was initiated in Singapore, which demonstrated the cultural feasibility and practicality of the FINGER interventions and a set of locally adapted interventions in an Asian population. The SINGER study is a 2-year randomized controlled trial that aims to test the efficacy and safety of these lifestyle changes, including diet and cardiovascular risk factor management, cognitive and physical exercises, in delaying cognitive decline in older adults at risk of dementia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 16, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

August 23, 2021

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

August 24, 2021

Status Verified

August 1, 2021

Enrollment Period

4.4 years

First QC Date

July 28, 2021

Last Update Submit

August 23, 2021

Conditions

Keywords

cognitive declinecognitive impairmentmulti-domain lifestyle interventionsdementiaelderly

Outcome Measures

Primary Outcomes (1)

  • Global Cognition

    Global cognition measured using the modified Neuropsychological Test Battery (mNTB) that includes: Visual Paired Associates, Logical Memory Recall of the Wechsler Memory Scale-Revised, Rey Auditory Verbal Learning, Digit Span, Word and Category Fluency test, Trail Making Test, Letter Digit Substitution test.

    Up to 2 years

Secondary Outcomes (23)

  • Episodic Memory

    Up to 2 years

  • Executive Function

    Up to 2 years

  • Processing Speed

    Up to 2 years

  • Clinical Dementia Rating-Sum of Boxes (CDR-SB)

    Up to 2 years

  • Alzheimer's Disease Cooperative Study Activities of Daily Living-Mild Cognitive Impairment-Activities of Daily Living Inventory (ADCS-MCI-ADL)

    Up to 2 years

  • +18 more secondary outcomes

Study Arms (2)

Structured Lifestyle Intervention

EXPERIMENTAL

Structured lifestyle modification program developed for participants targeting diet, physical exercise, cognitive training, and social stimulation.

Behavioral: Structured Lifestyle Intervention

Self-Guided Intervention

EXPERIMENTAL

General health information provided to participants.

Behavioral: Self-Guided Intervention

Interventions

Structured Lifestyle Intervention (SLI) involves providing participants with intensive structure and support by a team of trainers to increase physical exercise, adhere to a healthy diet, cognitive training, increase intellectual/social stimulation, and better manage vascular risk factors.

Also known as: SLI
Structured Lifestyle Intervention

In the Self-Guided Intervention (SGI), education about the importance of a healthy lifestyle as a preventive strategy and support to encourage change will be provided.

Also known as: SGI
Self-Guided Intervention

Eligibility Criteria

Age60 Years - 77 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60-77 years
  • Able to understand English/Chinese
  • Risk of dementia: Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) dementia risk score \>6 indicating the presence of modifiable risk factors Modifiable lifestyle factors (fulfilling at least one of the following LIBRA index for diet, cognitive activity, physical activity)
  • Cognitive performance at the mean level or slightly lower than expected for age (MoCA ≥18, ≤27)
  • No plans to travel outside of Singapore for an extended period of time over the course of the study
  • Free of physical disabilities that preclude participation in the study
  • Willing to complete all study-related activities for 24 months
  • Willing to be randomized to either lifestyle intervention group

You may not qualify if:

  • malignant diseases
  • dementia
  • substantial cognitive decline (MoCA\<18)
  • major depression
  • symptomatic cardiovascular disease
  • revascularisation within 1 year
  • severe loss of vision, hearing or communicative ability
  • other conditions inhibiting from safe engagement in the prescribed intervention and other conditions preventing cooperation, as judged by the study physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

National University Hospital

Singapore, 117600, Singapore

RECRUITING

National University of Singapore, Yong Loo Lin School of Medicine

Singapore, 117600, Singapore

RECRUITING

National Neuroscience Institute @ Tan Tock Seng Campus (NNI @ TTSH campus)

Singapore, 308433, Singapore

NOT YET RECRUITING

Related Publications (2)

  • Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. Epub 2015 Mar 12.

    PMID: 25771249BACKGROUND
  • Chew KA, Xu X, Siongco P, Villaraza S, Phua AKS, Wong ZX, Chung CY, Tang N, Chew E, Henry CJ, Koo E, Chen C. SINgapore GERiatric intervention study to reduce physical frailty and cognitive decline (SINGER)-pilot: A feasibility study. Alzheimers Dement (N Y). 2021 Mar 15;7(1):e12141. doi: 10.1002/trc2.12141. eCollection 2021.

    PMID: 33748399BACKGROUND

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Condition Hierarchy (Ancestors)

TauopathiesNeurodegenerative Diseases

Study Officials

  • Christopher LH Chen, MD

    National University of Singapore

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 28, 2021

First Posted

August 16, 2021

Study Start

August 23, 2021

Primary Completion

December 31, 2025

Study Completion

January 31, 2026

Last Updated

August 24, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Interested collaborators may put in a request.

Locations